Indonesia's BPOM Issues Emergency Use Authorization for Sinovac's Covid-19 Vaccine

    Fachri Audhia Hafiez - 11 January 2021 18:00 WIB
    Indonesia's BPOM Issues Emergency Use Authorization for Sinovac's Covid-19 Vaccine
    Illustration (Photo:Medcom.id)
    Jakarta: Indonesia's Food and Drug Monitoring Agency (BPOM) has officially issued the emergency use authorization (EUA) for Sinovac Biotech's covid-19 vaccine.

    "BPOM issued the EUA for Coronavac," said BPOM Chairman Penny K Lukito during a virtual press conference here on Monday afternoon.

    "This decision was based on comprehensive evaluations and discussions and supported by scientific data and evidence," the BPOM head explained.

    Last week, The Indonesian Ulema Council (MUI) has also declared the Sinovac covid-19 vaccine to be used in Indonesia is halal.

    The Indonesian government plans to launch the covid-19 vaccination program later this week. President Joko Widodo (Jokowi) is scheduled to get vaccinated on Wednesday. The president will be the first persone to receive covid-19 vaccination in Indonesia.

    "Based on trials in Bandung, the efficacy of Coronavac is 65.3 percent. Meanwhile, based on trials in Turkey and Brazil, the efficacy of the vaccine is 91.25 percent and 78 percent, respectively," Penny revealed.

    (WAH)

    Bagaimana tanggapan anda mengenai artikel ini?

    Cara untuk mendapatkan Berita terbaru dari kami.

    Ikuti langkah berikut ini untuk mendapatkan notifikasi

    1. Akses Pengaturan/Setting Browser Anda
    2. Akses Notifications pada Pengaturan/Setting Browser Anda
    3. Cari https://m.medcom.id pada List Sites Notifications
    4. Klik Allow pada List Notifications tersebut

    Anda Selesai.

    Powered by Medcom.id